Pfizer, the international pharmaceuticals giant helmed by Thessaloniki-born Dr. Albert Bourla, made a staggering $36.8 billion on its first-in-the-world coronavirus vaccine last year. First authorized for emergency use in December of 2020, just nine months after the virus began to shut down the country’s economy, the Pfizer vaccine, which was produced with Germany’s much smaller […]
Read the full story on GreekReporter.com.
